REAGEN LLC is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of, and investment in, products and assets which fall into two core categories - nutraceuticals and pharmaceuticals.
We are focused primarily on oncology and diseases with unmet needs. Our research is conducted at in-house laboratories, as well as in conjunction with partner companies and academic institutions around the world.So far, significant progress has been made.
The company’s platform technology is built upon a naturally-occurring sodium channel blocking compound found primarily in fish. REAGEN’s lead product based on the compound is being developed as a medication to provide relief for various chronic pain conditions.
REAGEN LLC,focusing on ELISA kits including clinical disease detecting kits,food&feed safety test kits and animal epidemic virus detecting kits in US for 6 yearsRead More